These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 8454330)
1. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Anaissie E; Hachem R; K-Tin-U C; Stephens LC; Bodey GP Infect Immun; 1993 Apr; 61(4):1268-71. PubMed ID: 8454330 [TBL] [Abstract][Full Text] [Related]
2. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa. Samaranayake YH; Wu PC; Samaranayake LP; Ho PL J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640 [TBL] [Abstract][Full Text] [Related]
3. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. Edwards JE; Montgomerie JZ; Ishida K; Morrison JO; Guze LB J Infect Dis; 1977 Feb; 135(2):294-7. PubMed ID: 320277 [TBL] [Abstract][Full Text] [Related]
4. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. Karyotakis NC; Dignani MC; Anaissie EJ Antimicrob Agents Chemother; 1995 Mar; 39(3):775-7. PubMed ID: 7793892 [TBL] [Abstract][Full Text] [Related]
5. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. Bistoni F; Vecchiarelli A; Cenci E; Sbaraglia G; Perito S; Cassone A Sabouraudia; 1984; 22(5):409-18. PubMed ID: 6505914 [TBL] [Abstract][Full Text] [Related]
6. Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis. Rossoni RD; Barbosa JO; Vilela SF; dos Santos JD; de Barros PP; Prata MC; Anbinder AL; Fuchs BB; Jorge AO; Mylonakis E; Junqueira JC PLoS One; 2015; 10(7):e0131700. PubMed ID: 26146832 [TBL] [Abstract][Full Text] [Related]
7. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Arendrup M; Horn T; Frimodt-Møller N Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088 [TBL] [Abstract][Full Text] [Related]
8. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345 [TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenicity of various species of Candida in mice immunodepressed with cyclophosphamide]. Sbaraglia G; D'Errico P; Serafini S; Vecchiarelli L; Perito S Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1421-6. PubMed ID: 6477757 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice. de Repentigny L; Phaneuf M; Mathieu LG Infect Immun; 1992 Nov; 60(11):4907-14. PubMed ID: 1399001 [TBL] [Abstract][Full Text] [Related]
12. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha. Matuschak GM; Lechner AJ Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186 [TBL] [Abstract][Full Text] [Related]
13. A novel murine model of disseminated trichosporonosis. Gokaslan A; Anaissie E Infect Immun; 1992 Aug; 60(8):3339-44. PubMed ID: 1639502 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185 [TBL] [Abstract][Full Text] [Related]
16. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Matthews RC; Rigg G; Hodgetts S; Carter T; Chapman C; Gregory C; Illidge C; Burnie J Antimicrob Agents Chemother; 2003 Jul; 47(7):2208-16. PubMed ID: 12821470 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370 [TBL] [Abstract][Full Text] [Related]
18. Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation. Hirayama T; Miyazaki T; Ito Y; Wakayama M; Shibuya K; Yamashita K; Takazono T; Saijo T; Shimamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H Sci Rep; 2020 Mar; 10(1):3814. PubMed ID: 32123235 [TBL] [Abstract][Full Text] [Related]
19. Potency of gastrointestinal colonization and virulence of Candida auris in a murine endogenous candidiasis. Abe M; Katano H; Nagi M; Higashi Y; Sato Y; Kikuchi K; Hasegawa H; Miyazaki Y PLoS One; 2020; 15(12):e0243223. PubMed ID: 33264362 [TBL] [Abstract][Full Text] [Related]
20. [Pathogenicity of various species of Candida in an experimental murine system]. Perito S; Vecchiarelli L; D'Errico P; Serafini S; Sbaraglia G Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1415-9. PubMed ID: 6477756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]